Data:AXA/2025/FY/Earnings release.json: Difference between revisions

"heading": "1 \u003Cnowiki\u003E|\u003C/nowiki\u003E Key figures: grossGross written premiums \u0026amp; other revenues by business line, FY24 vs FY25.",

"content": "**Key figures: grossGross written premiums \u0026 other revenues (Gross written premiums \u0026 other revenues) by business line (Business mix), FY24 (Full year 2024) vs FY25 (Full year 2025).**\n\n| In EUR million | FY24 | FY25 | Change on a reported basis | Change at comparable basis |\n| --- | --- | --- | --- | --- |\n| Gross written premiums \u0026 other revenues (1) | 110,316 | 115,524 | +5% | +6% |\n| o/w Property \u0026 Casualty (Property \u0026 casualty) | 56,514 | 58,038 | +3% | +5% |\n| o/w Life \u0026 Health (Life \u0026 health) | 51,983 | 56,512 | +9% | +8% |\n| o/w Asset Management (AXA Investment Managers) | 1,701 | 875 | n.m. | n.m. |\n\n**Key figures: underlyingUnderlying earnings and net income, FY24 vs FY25.**\n\n| | FY24 | FY25 | Change on a reported basis | Change at constant Forex |\n| --- | --- | --- | --- | --- |\n| Underlying earnings (2) | 8,078 | 8,368 | +4% | +6% |\n| Net income | 7,886 | 9,797 | +24% | +26% |\n\n**Solvency II ratio,: FY24 vs FY25.**\n\n| | FY24 | FY25 | Change on a reported basis | |\n| --- | --- | --- | --- | --- |\n| Solvency II ratio (%) (5) | 216% | 224% | +9 pts | — |\n\n=== Activity indicators ==="

"heading": "4 \u003Cnowiki\u003E|\u003C/nowiki\u003E Property \u0026amp; Casualty: gross written premiums and other revenues by business line, FY24 vs FY25.",

"content": "**Property \u0026 Casualty (Property \u0026 casualty): gross written premiums and other revenues by business line (Business mix), FY24 (Full year 2024) vs FY25 (Full year 2025).**\n\n| In EUR billion | FY24 | FY25 | Change on a comparable basis | FY25 Price effect(12) (in %) |\n| --- | --- | --- | --- | --- |\n| Gross written premiums and other revenues | 56.5 | 58.0 | +5% | +2.9% |\n| o/w Commercial lines(11) | 34.9 | 35.8 | +4% | +1.9% |\n| o/w Personal lines | 19.1 | 19.7 | +7% | +5.2% |\n| o/w AXA XL Reinsurance | 2.5 | 2.6 | +8% | +0.3% |\n\n**Property \u0026 Casualty: combined ratio and underlying earnings, FY24 vs FY25.**\n\n| | FY24 | FY25 | Change at constant Forex |\n| --- | --- | --- | --- |\n| All-Year Combined ratio | 91.0% | 90.6% | -0.3 pt |\n| Underlying earnings | 5,510 | 5,872 | +9% |"

"heading": "6 \u003Cnowiki\u003E|\u003C/nowiki\u003E Key figures: Life \u0026amp; Health new business metrics: PVEP, NB CSM, NBV, NBV margin, and net flows, FY24 vs FY25.",

"content": "**Key figures: Life \u0026 Health (Life \u0026 health).**\n\n| newIn businessEUR metrics:billion PVEP, NB CSM, NBV, NBV margin, and net flows,| FY24 (Full year 2024) vs| FY25 (Full year 2025).**\n\n| In EUR billion | FY24 | FY25 | Change on a comparable basis |\n| --- | --- | --- | --- |\n| Gross written premiums \u0026 other revenues (Gross written premiums \u0026 other revenues) | 52.0 | 56.5 | +8% |\n| o/w Life | 34.5 | 37.5 | +9% |\n| o/w Health | 17.5 | 19.0 | +5% |\n| PVEP(1,21) | 50.9 | 49.4 | -2% |\n| NB CSM(1,21) | 2.2 | 2.2 | +3% |\n| NBV (post-tax)(1,21) | 2.3 | 2.2 | 0% |\n| NBV margin(1,21) | 4.4% | 4.5% | +0.1 pt |\n| Net flows(21) | +1.5 | +5.4 | — |\n\n**Life \u0026 Health underlying earnings by business line (Business mix), FY24 vs FY25.**\n\n| | FY24 | FY25 | Change at constant forex |\n| --- | --- | --- | --- |\n| Underlying earnings | 3,323 | 3,501 | +7% |\n| o/w Life | 2,636 | 2,715 | +4% |\n| o/w Health | 687 | 787 | +17% |\n\n=== Gross written premiums \u0026 other revenues were up 8% to Euro 56.5 billion. ==="

"heading": "scopeScope of reporting by geography and entity",

"heading": "10 \u003Cnowiki\u003E|\u003C/nowiki\u003E Gross Written Premiums and Other Revenuesrevenues by geography and business line, FY24 vs FY25.",

"content": "**Gross Written Premiums and Other Revenuesrevenues by geography and business line (Business mix), FY24 (Full year 2024) vs FY25 (Full year 2025).**\n\n| In EUR million | Gross Written Premiums and Other Revenues FY24 | Gross Written Premiums and Other Revenues FY25 | Gross Written Premiums and Other Revenues Change on a reported basis | Gross Written Premiums and Other Revenues Change on a comparable basis | o/w Property \u0026 Casualty (Property \u0026 casualty) FY25 | o/w Property \u0026 Casualty Change on a comparable basis | o/w Life \u0026 Health (Life \u0026 health) FY25 | o/w Life \u0026 Health Change on a comparable basis | o/w Asset Management (AXA Investment Managers) FY25 | o/w Asset Management Change on a comparable basis |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| France(i) | 28,996 | 30,598 | +6% | +6% | 9,648 | +7% | 20,852 | +5% | — | — |\n| Europe (AXA Europe) | 39,298 | 43,005 | +9% | +6% | 21,257 | +4% | 21,748 | +8% | — | — |\n| AXA XL | 19,383 | 19,277 | -1% | +4% | 19,159 | +4% | 118 | -8% | — | — |\n| Asia, Africa \u0026 EME-LATAM (AXA Asia, Africa \u0026 EME-LATAM) | 19,083 | 19,925 | +4% | +13% | 6,257 | +13% | 13,668 | +13% | — | — |\n| Transversal | 1,856 | 1,844 | -1% | -1% | 1,718 | -1% | 126 | -8% | — | — |\n| AXA Investment Managers | 1,701 | 875 | -49% | +4% | — | — | — | — | 875 | +4% |\n| Total(i) | 110,316 | 115,524 | +5% | +6% | 58,038 | +5% | 56,512 | +8% | 875 | +4% |\n\n(i) Including Banking revenues amounting to Euro 99 million in FY25 and Euro 118 million in FY24.\n\n== Appendix 2: Underlying earnings by geography and by business line =="

"heading": "14 \u003Cnowiki\u003E|\u003C/nowiki\u003E P\u0026amp;C: Priceprice effects by country and business line, FY25 with 2026 Market pricing trends.",

"content": "**P\u0026C (Property \u0026 casualty): Priceprice effects by country and business line (Business mix), FY25 (Full year 2025) with 2026 (Year 2026) Market pricing trends.**\n\n| FY25 (in %) | Commercial lines | Personal lines | AXA XL Reinsurance | 2026 Market pricing trends |\n| --- | --- | --- | --- | --- |\n| France (AXA France) | +4.0% | +3.3% | — | Moderation of price increase |\n| Europe (AXA Europe) | +3.1% | +5.4% | — | — |\n| Switzerland | +3.0% | +5.0% | — | Continued price increases both in Personal and Commercial lines |\n| Germany | +3.1% | +10.3% | — | Moderation of price increase, notably in Personal lines following two years of high price increases to counter claims inflation |\n| Belgium \u0026 Luxembourg | +2.5% | +4.4% | — | Price increase broadly in line with 2025 |\n| UK \u0026 Ireland | +1.4% | -2.6% | — | In UK Personal lines, continuation of current trend, continued moderation in Commercial lines |\n| Spain | +8.8% | +8.6% | — | Moderation of price increase |\n| Italy | +5.2% | +5.3% | — | Moderation of price increase |\n| AXA XL(ii) | +0.2% | — | +0.3% | Softening prices with conditions varying by lines |\n| Asia, Africa \u0026 EME-LATAM (AXA Asia, Africa \u0026 EME-LATAM) | +3.8% | +7.1% | — | Moderation of price increase |\n| Total | +1.9% | +5.2% | +0.3% | — |\n\n(i) i. Price effect calculated as a percentage of total gross written premiums in the prior year.\n(ii) ii. Price increase on renewals at +0.3% in Insurance and +0.2% in Reinsurance. Price increase on renewals calculated as a percentage of renewed premiums.\n\n== Appendix 5: Life \u0026 Health – gross written premiums \u0026 other revenues and growth by business line =="

"heading": "15 \u003Cnowiki\u003E|\u003C/nowiki\u003E Life \u0026amp; Health gross written premiums \u0026amp; other revenues byand geographygrowth andby business line, FY25.",

"content": "**Life \u0026 Health (Life \u0026 health) gross written premiums \u0026 other revenues (Gross written premiums \u0026 other revenues) byand geographygrowth andby business line (Business mix), FY25 (Full year 2025).**\n\n| Gross written premiums \u0026 other revenues In EUR million | Total FY25 | Total Change(i) | o/w Protection FY25 | o/w Protection Change(i) | o/w G/A Savings FY25 | o/w G/A Savings Change(i) | o/w Unit-Linked FY25 | o/w Unit-Linked Change(i) | o/w Health FY25 | o/w Health Change(i) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| France (AXA France) | 20,852 | +5% | 4,650 | +6% | 5,483 | +4% | 5,109 | +10% | 5,611 | +2% |\n| Europe (AXA Europe) | 21,748 | +8% | 5,090 | +4% | 4,444 | +18% | 3,419 | +10% | 8,795 | +4% |\n| AXA XL | 118 | -8% | 59 | -6% | 59 | -10% | - | - | - | - |\n| Asia, Africa \u0026 EME-LATAM (AXA Asia, Africa \u0026 EME-LATAM) | 13,668 | +13% | 7,454 | +19% | 971 | -31% | 761 | +63% | 4,483 | +11% |\n| Transversal | 126 | -8% | - | - | - | - | - | - | 126 | -8% |\n| Total | 56,512 | +8% | 17,253 | +11% | 10,957 | +4% | 9,289 | +13% | 19,014 | +5% |\n| o/w short-term(ii) | 17,651 | +6% | 4,337 | +6% | — | — | — | — | 13,314 | +6% |\n\n(i) Changes are at comparable basis (constant forex, scope and methodology)\n(ii) Short-term business refers to insurance activities measured using the Premium Allocation Approach ('PAA'). Short-term business margin is analyzed using the Combined Ratio. Short-term business refers here to Life Pure Protection and Health when measured using the PAA period\n\n== Appendix 6: New business volume (PVEP), new business value (NBV), and NBV margin =="